Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue engineering in urology.

A Atala1

  • 1Department of Urology, Children's Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA. Atala@a1.tch.harvard.edu

Current Urology Reports
|June 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of urology residency training between the United States and China.

Actas urologicas espanolas·2022
Same author

Ibuprofen loaded PLA nanofibrous scaffolds increase proliferation of human skin cells in vitro and promote healing of full thickness incision wounds in vivo.

Journal of biomedical materials research. Part B, Applied biomaterials·2015
Same author

Assessments of injectable alginate particle-embedded fibrin hydrogels for soft tissue reconstruction.

Biomedical materials (Bristol, England)·2013
Same author

Decellularization for whole organ bioengineering.

Biomedical materials (Bristol, England)·2013
Same author

Controlled heparin conjugation on electrospun poly(ε-caprolactone)/gelatin fibers for morphology-dependent protein delivery and enhanced cellular affinity.

Acta biomaterialia·2012
Same author

Embryoid body formation of human amniotic fluid stem cells depends on mTOR.

Oncogene·2009
Same journal

Effective Mentorship in Urology Fellowship Training: Qualities, Models, and Equity.

Current urology reports·2026
Same journal

Management of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis.

Current urology reports·2026
Same journal

Lower Urinary Tract Symptoms as an Indicator of Occult Neurologic Disease: A System-first Framework for Urologic Practice.

Current urology reports·2026
Same journal

Association Between Ambient Temperature and Urolithiasis: A Systematic Review and Meta-analysis.

Current urology reports·2026
Same journal

Is Open Partial Nephrectomy Still an Option in the Robotic Era?

Current urology reports·2026
Same journal

Artificial Intelligence in Urologic Documentation: A Review of Emerging Capabilities and the Ongoing Need for Human Oversight.

Current urology reports·2026
See all related articles

Tissue engineering offers promising solutions for genitourinary reconstruction using biomaterials and cells. This approach aims to restore function in damaged or lost organs, with emerging clinical applications showing future potential.

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Urology

Background:

  • Genitourinary organs can be damaged or lost due to various conditions, necessitating reconstructive procedures.
  • Tissue engineering principles, including cell transplantation and materials science, are applied to develop functional biological substitutes.
  • Both synthetic and natural biodegradable materials serve as scaffolds or cell delivery vehicles.

Purpose of the Study:

  • To review the application of tissue engineering in urologic organ reconstruction.
  • To highlight experimental and clinical advancements in engineered urologic tissues.
  • To discuss the future potential of tissue engineering in urology.

Main Methods:

  • Utilizing matrices alone to guide natural tissue regeneration.

Related Experiment Videos

  • Employing matrices seeded with cells (synthetic or natural).
  • Investigating various biodegradable materials like polyglycolic acid, poly-l-lactic acid, and collagen derivatives.

    • Main Results:

    • Tissue engineering has been experimentally applied to bladder, ureter, urethra, kidney, testis, and genitalia.
    • Clinical applications include cell-based therapies for incontinence and urethral/bladder reconstruction.
    • Fetal applications have also been explored.

    Conclusions:

    • Tissue engineering demonstrates significant potential for reconstructing damaged or lost genitourinary organs.
    • Current clinical applications show promise, with ongoing research expanding its utility.
    • Engineered urologic tissues are poised for broader clinical integration in the future.